the effect of oral liothyronin in patients outcome with congenital Cardiac surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180502039507N1

Enrollment

Registered

2019-04-27

Start date

2018-06-16

Completion date

Unknown

Last updated

2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sick euthyroid syndrome. Sick-euthyroid syndrome

Interventions

Intervention 1: Intervention group: 1 placbo. Intervention 2: Intervention group: 20 patients befor surgery give 2micro per kilogram levothyronine. Intervention 3: Intervention group:20 patients befor

Eligibility

Sex/Gender

All

Age

6 Months to 60 Months

Inclusion criteria

Inclusion criteria: in this study that do randomize 80 pateint (upper6 mounths lower 5years)with under cardiopulmonary bypas in cardiac surgery

Exclusion criteria

Exclusion criteria: impaired thyroid function test befor surgery

Design outcomes

Primary

Measure	Time frame
Effect of levothyronine in cardiac function after cardiac surgery(long of intubation.long of icu addmition.inotrope dosage). Timepoint: Thyroid function test befor surgery and 24 hours after surgery. Method of measurement: Icu addmision and long of intubation based on day. and inotrope dose micrgram per kilogram.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Omidi Farzin

Shahid Beheshti University of Medical Sciences

ttdzh@yahoo.com+98 21 4465 4351

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026